Prescription drug · BLA
Exdensur (Depemokimab) NDC 0173-0927
Depemokimab 100 mg/mL · Injection, Solution · Subcutaneous · GlaxoSmithKline LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0173-0927-42 | 00173092742 | 1 SYRINGE in 1 CARTON (0173-0927-42) / 1 mL in 1 SYRINGEMarketed from Dec 16, 2025 | |
| 0173-0927-61 | 00173092761 | 1 SYRINGE in 1 CARTON (0173-0927-61) / 1 mL in 1 SYRINGEMarketed from Mar 30, 2026 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Exdensur
- Generic name (nonproprietary)
- depemokimab
- Active ingredients
- Depemokimab — 100 mg/mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- GlaxoSmithKline LLCNDC labeler code 0173
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761458
- Marketing start
- Listing expires
- Identifiers
- Product ID 0173-0927_ea9e3787-11e0-4516-b419-db3c219a057cSPL ID ea9e3787-11e0-4516-b419-db3c219a057cSPL set ID 30332b20-2ac0-42ad-a775-d3ca7f5fe29fRxCUI 2729271, 2729278UNII D16EQP0KKH
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400173092742followed by a unit qualifier and the quantityPackage 00173-0927-42. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EXDENSUR is indicated for the add‑on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older. Limitations of Use EXDENSUR is not indicated for the relief of acute bronchospasm or status asthmaticus [see Warnings and Precautions ( 5.2 )] . EXDENSUR is an interleukin‑5 (IL‑5) antagonist, a monoclonal antibody (humanized immunoglobulin G1 [IgG1] kappa) indicated for add‑on maintenance treatment of severe asthma characterized by an eosinophilic phenotype in adult and pediatric patients aged 12 years and older. ( 1 ) Limitations of Use : Not for relief of acute bronchospasm or status asthmaticus. ( 1 )…
Excerpt only. Read the full label for complete information.
About NDC 0173-0927
- What is NDC 0173-0927?
- 0173-0927 is the product NDC for Exdensur (depemokimab), Depemokimab 100 mg/mL injection, solution, listed with the FDA by GlaxoSmithKline LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Exdensur (Depemokimab).
- What is the active ingredient?
- Depemokimab.
- Who is the labeler?
- GlaxoSmithKline LLC, NDC labeler code 0173. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Exdensur?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.